Guttalax

Guttalax is an over‑the‑counter oral product whose active ingredient is sodium picosulfate. It is supplied in a tablet or powder form (strength not specified) and belongs to the stimulant laxative class. Sodium picosulfate is metabolized by colonic bacteria to an active compound that promotes peristalsis and fluid secretion, helping to relieve occasional constipation. The product is marketed in the European Union and is intended for short‑term use under adult supervision.

Guttalax is indicated for the temporary relief of occasional constipation in adults.

- Mild to moderate constipation that has not responded to dietary fiber or fluid increase. - Preparation for diagnostic procedures that require an empty colon, when directed by a healthcare professional. - Occasional irregular bowel movements associated with travel or changes in routine. - Constipation related to reduced physical activity or short‑term medication side effects. - Use as part of a bowel‑cleansing regimen prior to colonoscopy, following physician guidance. - It is formulated for oral administration and is not intended for chronic use.

The safety profile of sodium picosulfate reflects its pharmacologic activity on the colon; side effects are generally related to increased intestinal motility and fluid shifts. Because the drug is activated by colonic bacteria, its effects begin several hours after ingestion, which can influence the type and frequency of adverse events.

Common: - Abdominal cramping or mild pain - Diarrhea or loose stools - Increased bowel urgency - Nausea or mild stomach discomfort - Bloating or a feeling of fullness in the abdomen

Serious: - Severe dehydration due to excessive fluid loss - Electrolyte imbalance such as low potassium - Rectal bleeding or severe abdominal pain - Allergic reaction such as rash, itching, or swelling

When using Guttalax, certain precautions help minimize risks and ensure appropriate use, especially for individuals with underlying health conditions.

- Do not use for chronic constipation without medical supervision. - Avoid use if you have intestinal blockage, severe abdominal pain, or inflammatory bowel disease. - Consult a healthcare professional before use during pregnancy or breastfeeding, as safety data are limited. - Maintain adequate fluid intake while taking the product to reduce the risk of dehydration. - Do not exceed the recommended dose; higher amounts increase the likelihood of electrolyte disturbances. - Discontinue use and seek medical advice if diarrhea persists for more than 24 hours.

Sodium picosulfate may affect the action of other medicines or be affected by them; reviewing potential interactions can help prevent unwanted effects.

Avoid: - Concurrent use with strong anticholinergic agents, as they may reduce the laxative effect. - Combination with other stimulant or osmotic laxatives, which can increase the risk of severe diarrhea and electrolyte loss. - Co‑administration with diuretics, because the combined fluid loss may exacerbate dehydration.

Use with caution: - Use together with antihypertensive drugs; fluid shifts could affect blood pressure control. - When taken with thyroid hormone replacement, altered absorption may occur. - Patients on anticoagulants should monitor for any changes in bleeding risk, although a direct interaction is not established.